Tekrardan Hoşgeldiniz
Cointime’a Katıl
Giriş Yap
Kayıt Ol
Gelen kutunuzu kontrol edin
Replimune Group
About
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer.
- Woburn,Massachusetts,United States
- 101 - 250
- http://replimune.com/
Details
- Last Funding Type
- Post-IPO Debt
- Last Funding Money Raised
- $200M
- Industries
- Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Mar 1, 2015
- Number Of Employee
- 101 - 250
- Operating Status
- Active
- Stock Symbol
- nasdaq:REPL
- Legal Name
- Replimune Group Inc.
Replimune Group develop the next generation of ‘oncolytic immunotherapies’ for the treatment of cancer. Replimune is developing novel, proprietary products intended to improve both the direct anti-tumor effects of selective virus replication and the potency of the immune response to the tumor antigens released. The Company’s Immulytic™ platform is designed to maximize systemic immune activation, in particular to tumor neoantigens, through robust viral mediated immunogenic tumor cell killing and the delivery of optimal combinations of immune activating proteins to the tumor and draining lymph nodes. The approach is expected to be highly synergistic with immune checkpoint blockade and other approaches to cancer treatment. Replimune intends to progress these therapies rapidly through clinical trials and to combine with other immuno-oncology products with complementary mechanisms of action at an early stage.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 7, 2022 | Post-IPO Equity | $225M | — | — | — | Detail |
| Oct 7, 2022 | Post-IPO Debt | $200M | 1 |
Hercules Capital
|
— | Detail |
| Jul 19, 2018 | IPO | $100.50M | — | — | — | Detail |
| Sep 8, 2017 | Series B | $55M | 8 |
Bain Capital Life Sciences
|
— | Detail |
| Sep 24, 2015 | Series A | $30M | 3 |
Atlas Venture
Omega Funds
|
— | Detail |
Investments
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jul 13, 2021
ClayStack
|
Seed | $5.20M | Blockchain | — |
|
Sep 12, 2019
Magic Spoon
|
Seed | $5.50M | Food and Beverage | — |
|
Jul 30, 2019
Solana
|
Seed | — | Blockchain | — |
|
Nov 4, 2009
Zynga
|
Series B | $15.18M | Gaming | — |
|
Sep 4, 2009
Foursquare
|
Series A | $1.35M | Advertising | — |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Hercules Capital
|
Yes | Post-IPO Debt |
|
Bain Capital Life Sciences
|
Yes | Series B |
|
|
Yes | Series B |
|
Atlas Venture
|
— | Series B |
Cormorant Asset Management
|
— | Series B |
Forbion Capital Partners
|
— | Series B |
Leerink Partners
|
— | Series B |
|
Omega Funds
|
— | Series B |
|
|
— | Series B |
Employee Profiles
